Pictet North America Advisors Sa Exact Sciences Corp Transaction History

Pictet North America Advisors Sa

  • $1.01 Trillion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $100,385 - $155,021
-3,140 Reduced 2.97%
102,700 $3.34 Billion
Q2 2022

Aug 05, 2022
SELL
$35.61 - $76.23 $118,866 - $254,455
-3,338 Reduced 3.06%
105,840 $4.17 Million
Q1 2022

May 06, 2022
SELL
$57.56 - $82.54 $954,287 - $1.37 Million
-16,579 Reduced 13.18%
109,178 $7.63 Million
Q4 2021

Feb 04, 2022
BUY
$72.5 - $100.68 $32,262 - $44,802
445 Added 0.36%
125,757 $9.79 Million
Q3 2021

Nov 10, 2021
BUY
$90.24 - $124.05 $879,479 - $1.21 Million
9,746 Added 8.43%
125,312 $12 Million
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $2.69 Million - $4 Million
28,691 Added 33.03%
115,566 $14.4 Million
Q1 2021

May 10, 2021
SELL
$116.57 - $155.01 $110,741 - $147,259
-950 Reduced 1.08%
86,875 $11.4 Million
Q4 2020

Feb 10, 2021
BUY
$99.61 - $142.12 $553,034 - $789,050
5,552 Added 6.75%
87,825 $11.6 Million
Q3 2020

Nov 10, 2020
SELL
$72.92 - $102.01 $52,137 - $72,937
-715 Reduced 0.86%
82,273 $8.39 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $319,391 - $531,364
5,729 Added 7.42%
82,988 $7.22 Million
Q1 2020

Apr 30, 2020
BUY
$37.9 - $104.44 $2.93 Million - $8.07 Million
77,259 New
77,259 $4.48 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pictet North America Advisors Sa Portfolio

Follow Pictet North America Advisors Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet North America Advisors Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email